1. Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway
    Jie Xi et al, 2023, BMC Pulmonary Medicine CrossRef
  2. Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response
    Cheng Li et al, 2022, Phytomedicine CrossRef
  3. A Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Pharmacological Mechanism of Astragalus membranaceus for Glioma
    Yu Feng et al, 2023, International Journal of Molecular Sciences CrossRef
  4. Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders—Is There a Breakthrough?
    Jelica Grujić-Milanović et al, 2023, Antioxidants CrossRef
  5. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
    Ran-ran Wang et al, 2022, Pharmacological Research CrossRef
  6. Lung inflammation perturbation by engineered nanoparticles
    Xiaofei Zhou et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef
  7. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
    Yongchao Zhao et al, 2023, Signal Transduction and Targeted Therapy CrossRef
  8. Astragaloside IV in Hypoxic Pulmonary Hypertension: an In Vivo and In Vitro Experiments
    null XinTian et al, 2022, Applied Biochemistry and Biotechnology CrossRef
  9. Review on the protective mechanism of astragaloside IV against cardiovascular diseases
    Chunkun Yang et al, 2023, Frontiers in Pharmacology CrossRef
  10. Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
    Xiuli Yang et al, 2023, Heliyon CrossRef
  11. Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension
    Enrico Gugliandolo et al, 2023, Pharmacological Research CrossRef
  12. Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling
    Jinchun Wu et al, 2022, Cardiovascular Diabetology CrossRef
  13. Effect of Qiling Jiaogulan Powder on Pulmonary Fibrosis and Pulmonary Arteriole Remodeling in Low-Temperature-Exposed Broilers
    Juan Yu et al, 2022, Animals CrossRef
  14. Matrine alleviates hypoxia‐induced inflammation and pulmonary vascular remodelling via RPS5/NF‐κB signalling pathway
    Mingxing Li et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
  15. Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities
    Zuomei Zeng et al, 2023, Current Issues in Molecular Biology CrossRef
  16. High-Throughput Phytochemical Unscrambling of Flowers Originating from Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) P. K. Hsiao and Astragalus membranaceus (Fisch.) Bug. by Applying the Intagretive Plant Metabolomics Method Using UHPLC−Q−TOF−MS/MS
    Qi Liu et al, 2023, Molecules CrossRef
  17. Insights into Endothelin Receptors in Pulmonary Hypertension
    Ruiqi Liu et al, 2023, International Journal of Molecular Sciences CrossRef
  18. Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats
    Fengyan Shen et al, 2022, Molecular Medicine Reports CrossRef
  19. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
    Zehui Xu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  20. Recent advances in the potential effects of natural products from traditional Chinese medicine against respiratory diseases targeting ferroptosis
    Tian Chen et al, 2024, Chinese Medicine CrossRef
  21. Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway
    Qin Yin et al, 2023, Journal of Pharmacy and Pharmacology CrossRef